Published in J Virol on February 01, 2005
Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science (2010) 3.62
Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. Immunity (2009) 2.44
Crystal structure of human adenovirus at 3.5 A resolution. Science (2010) 2.17
A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol (2006) 2.16
Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments. J Virol (2006) 1.96
Current advances and future challenges in Adenoviral vector biology and targeting. Curr Gene Ther (2007) 1.94
Parvoviral virions deploy a capsid-tethered lipolytic enzyme to breach the endosomal membrane during cell entry. Proc Natl Acad Sci U S A (2005) 1.85
Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator. J Virol (2007) 1.84
Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A (2006) 1.48
Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat Med (2013) 1.45
Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane. Proc Natl Acad Sci U S A (2006) 1.44
Adenovirus infections in immunocompetent and immunocompromised patients. Clin Microbiol Rev (2014) 1.43
VP2 cleavage and the leucine ring at the base of the fivefold cylinder control pH-dependent externalization of both the VP1 N terminus and the genome of minute virus of mice. J Virol (2006) 1.41
Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. J Virol (2008) 1.36
CAR-associated vesicular transport of an adenovirus in motor neuron axons. PLoS Pathog (2009) 1.35
Cyclophilins facilitate dissociation of the human papillomavirus type 16 capsid protein L1 from the L2/DNA complex following virus entry. J Virol (2012) 1.34
Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog (2010) 1.34
Adenovirus membrane penetration activates the NLRP3 inflammasome. J Virol (2010) 1.30
Adenovirus transport via direct interaction of cytoplasmic dynein with the viral capsid hexon subunit. Cell Host Microbe (2009) 1.30
Early events during BK virus entry and disassembly. J Virol (2008) 1.30
Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. EMBO J (2008) 1.30
A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog (2010) 1.29
Functional genetic and biophysical analyses of membrane disruption by human adenovirus. J Virol (2011) 1.28
A chaperone-activated nonenveloped virus perforates the physiologically relevant endoplasmic reticulum membrane. J Virol (2007) 1.27
Adenovirus. Curr Top Microbiol Immunol (2010) 1.27
Cryo-electron microscopy structure of adenovirus type 2 temperature-sensitive mutant 1 reveals insight into the cell entry defect. J Virol (2009) 1.27
Conservation of intrinsic disorder in protein domains and families: II. functions of conserved disorder. J Proteome Res (2006) 1.27
Insights into adenovirus host cell interactions from structural studies. Virology (2008) 1.25
Molecular evolution of human species D adenoviruses. Infect Genet Evol (2011) 1.25
Structure and uncoating of immature adenovirus. J Mol Biol (2009) 1.23
Antiviral mechanisms of human defensins. J Mol Biol (2013) 1.22
Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: indirect complement activation by virions in vivo. J Virol (2009) 1.18
Structures and organization of adenovirus cement proteins provide insights into the role of capsid maturation in virus entry and infection. Proc Natl Acad Sci U S A (2014) 1.18
Tropism-modification strategies for targeted gene delivery using adenoviral vectors. Viruses (2010) 1.17
An N-terminal domain of adenovirus protein VI fragments membranes by inducing positive membrane curvature. Virology (2010) 1.17
Innate immunity to adenovirus. Hum Gene Ther (2014) 1.15
Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys. J Virol (2012) 1.15
The role of capsid maturation on adenovirus priming for sequential uncoating. J Biol Chem (2012) 1.13
Latest insights on adenovirus structure and assembly. Viruses (2012) 1.13
Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection. J Virol (2010) 1.12
Adenovirus type 5 rupture of lysosomes leads to cathepsin B-dependent mitochondrial stress and production of reactive oxygen species. J Virol (2011) 1.10
Strategies to overcome host immunity to adenovirus vectors in vaccine development. Expert Rev Vaccines (2009) 1.08
Cryo-electron microscopy structure of an adenovirus-integrin complex indicates conformational changes in both penton base and integrin. J Virol (2009) 1.08
Genetic reconstitution of the human adenovirus type 2 temperature-sensitive 1 mutant defective in endosomal escape. Virol J (2009) 1.07
Transcriptional activation of the adenoviral genome is mediated by capsid protein VI. PLoS Pathog (2012) 1.06
Alpha-synuclein induces lysosomal rupture and cathepsin dependent reactive oxygen species following endocytosis. PLoS One (2013) 1.05
Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport. J Virol (2008) 1.04
Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections. Bioorg Med Chem (2005) 1.02
A cytosolic chaperone complexes with dynamic membrane J-proteins and mobilizes a nonenveloped virus out of the endoplasmic reticulum. PLoS Pathog (2014) 1.02
Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways. J Virol (2006) 1.02
From touchdown to transcription: the reovirus cell entry pathway. Curr Top Microbiol Immunol (2010) 1.01
Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. AAPS J (2009) 1.01
The antiviral restriction factors IFITM1, 2 and 3 do not inhibit infection of human papillomavirus, cytomegalovirus and adenovirus. PLoS One (2014) 0.99
Lysosomal localization and mechanism of membrane penetration influence nonenveloped virus activation of the NLRP3 inflammasome. Virology (2011) 0.98
Virus strategies for passing the nuclear envelope barrier. Nucleus (2012) 0.98
Spatiotemporal dynamics of adenovirus membrane rupture and endosomal escape. J Virol (2012) 0.97
DNA genome size affects the stability of the adenovirus virion. J Virol (2008) 0.96
A positive-feedback mechanism promotes reovirus particle conversion to the intermediate associated with membrane penetration. Proc Natl Acad Sci U S A (2008) 0.96
Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer. ACS Nano (2009) 0.95
Low endocytic pH and capsid protein autocleavage are critical components of Flock House virus cell entry. J Virol (2009) 0.95
Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. PLoS One (2013) 0.95
The dynactin complex enhances the speed of microtubule-dependent motions of adenovirus both towards and away from the nucleus. Viruses (2011) 0.94
Adenovirus composition, proteolysis, and disassembly studied by in-depth qualitative and quantitative proteomics. J Biol Chem (2014) 0.94
Crystallization and preliminary X-ray diffraction analysis of human adenovirus. Virology (2010) 0.94
Virion factors that target Daxx to overcome intrinsic immunity. J Virol (2013) 0.93
Viral weapons of membrane destruction: variable modes of membrane penetration by non-enveloped viruses. Curr Opin Virol (2011) 0.93
Adenovirus as a carrier for the development of influenza virus-free avian influenza vaccines. Expert Rev Vaccines (2009) 0.92
Structure of human adenovirus. Curr Opin Virol (2012) 0.91
Particle tracking of intracellular trafficking of octaarginine-modified liposomes: a comparative study with adenovirus. Mol Ther (2010) 0.91
Monitoring dynamics of human adenovirus disassembly induced by mechanical fatigue. Sci Rep (2013) 0.90
Regulation of a viral proteinase by a peptide and DNA in one-dimensional space: I. binding to DNA AND to hexon of the precursor to protein VI, pVI, of human adenovirus. J Biol Chem (2012) 0.90
Peptide-modified vectors for nucleic acid delivery to neurons. J Control Release (2008) 0.90
Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model. J Virol (2012) 0.89
A role for transportin in the nuclear import of adenovirus core proteins and DNA. Traffic (2007) 0.89
The cleaved N-terminus of pVI binds peripentonal hexons in mature adenovirus. J Mol Biol (2014) 0.89
Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm. ACS Nano (2011) 0.89
Exploiting endocytosis for nanomedicines. Cold Spring Harb Perspect Biol (2013) 0.89
Rescue of maturation-defective flock house virus infectivity with noninfectious, mature, viruslike particles. J Virol (2007) 0.89
Mechanistic aspects of adenovirus serotype 2 inactivation with free chlorine. Appl Environ Microbiol (2010) 0.88
Adenovirus recruits dynein by an evolutionary novel mechanism involving direct binding to pH-primed hexon. Viruses (2011) 0.88
Structure, function and dynamics in adenovirus maturation. Viruses (2014) 0.88
Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy. Curr Pharm Des (2014) 0.88
Host cell autophagy modulates early stages of adenovirus infections in airway epithelial cells. J Virol (2012) 0.87
Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction. J Virol (2014) 0.87
Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction. PLoS One (2011) 0.87
An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. PLoS One (2013) 0.87
Poxvirus membrane biogenesis: rupture not disruption. Cell Microbiol (2012) 0.87
How cells tune viral mechanics--insights from biophysical measurements of influenza virus. Biophys J (2014) 0.87
A direct and versatile assay measuring membrane penetration of adenovirus in single cells. J Virol (2013) 0.86
Determinants of strain-specific differences in efficiency of reovirus entry. J Virol (2010) 0.86
Incoming human papillomavirus type 16 genome resides in a vesicular compartment throughout mitosis. Proc Natl Acad Sci U S A (2016) 0.85
Dissecting the functional domains of a nonenveloped virus membrane penetration peptide. J Virol (2009) 0.85
Molecular determinants of proteolytic disassembly of the reovirus outer capsid. J Biol Chem (2012) 0.85
Disulfide-bond formation by a single cysteine mutation in adenovirus protein VI impairs capsid release and membrane lysis. Virology (2012) 0.84
The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid. J Virol (2013) 0.84
The role of cellular adhesion molecules in virus attachment and entry. Philos Trans R Soc Lond B Biol Sci (2015) 0.83
SV40 late protein VP4 forms toroidal pores to disrupt membranes for viral release. Biochemistry (2013) 0.83
A new link between virus cell entry and inflammation: adenovirus interaction with integrins induces specific proinflammatory responses. Mol Ther (2009) 0.83
The amphipathic helix of adenovirus capsid protein VI contributes to penton release and postentry sorting. J Virol (2014) 0.82
pH-Dependent lytic peptides discovered by phage display. Biochemistry (2006) 0.82
Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol (1999) 33.07
The PSIPRED protein structure prediction server. Bioinformatics (2000) 20.58
Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (1997) 14.41
Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell (1993) 13.21
Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat Struct Biol (1996) 8.57
Stepwise dismantling of adenovirus 2 during entry into cells. Cell (1993) 6.34
Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat Struct Biol (2001) 4.66
CD46 is a cellular receptor for group B adenoviruses. Nat Med (2003) 4.35
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol (1987) 3.65
Integrin alpha v beta 5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol (1994) 3.42
Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy. EMBO J (1993) 3.27
Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol (2002) 2.93
Genetic analysis of adenovirus type 2 III. Temperature sensitivity of processing viral proteins. J Virol (1976) 2.88
Molecular composition of the adenovirus type 2 virion. J Virol (1985) 2.72
Adenovirus type 11 uses CD46 as a cellular receptor. J Virol (2003) 2.52
The role of the adenovirus protease on virus entry into cells. EMBO J (1996) 2.44
The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. J Virol (2004) 2.11
Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Sci (1994) 2.06
Involvement of the vacuolar H(+)-ATPase in animal virus entry. J Gen Virol (1994) 2.06
Enhancement of reovirus infectivity by extracellular removal or alteration of the virus capsid by proteolytic enzymes. J Gen Virol (1970) 2.04
Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein micro 1 mediates membrane disruption. J Virol (2002) 2.02
The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol. J Virol (2000) 1.95
Viral DNA and a viral peptide can act as cofactors of adenovirus virion proteinase activity. Nature (1993) 1.86
Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol (2004) 1.77
Evidence that the penton base of adenovirus is involved in potentiation of toxicity of Pseudomonas exotoxin conjugated to epidermal growth factor. Mol Cell Biol (1984) 1.76
pH-dependent lysis of liposomes by adenovirus. Biochemistry (1986) 1.74
Putative autocleavage of outer capsid protein micro1, allowing release of myristoylated peptide micro1N during particle uncoating, is critical for cell entry by reovirus. J Virol (2004) 1.69
Adenovirus-dependent release of 51Cr from KB cells at an acidic pH. J Biol Chem (1984) 1.62
The delta region of outer-capsid protein micro 1 undergoes conformational change and release from reovirus particles during cell entry. J Virol (2003) 1.56
Kinetic analysis of the effect of poliovirus receptor on viral uncoating: the receptor as a catalyst. J Virol (2001) 1.46
Specific cleavage of ribosomal RNA caused by alpha sarcin. Nucleic Acids Res (1977) 1.45
Role of a low-pH environment in adenovirus enhancement of the toxicity of a Pseudomonas exotoxin-epidermal growth factor conjugate. J Virol (1984) 1.44
Reovirus polypeptide sigma 3 and N-terminal myristoylation of polypeptide mu 1 are required for site-specific cleavage to mu 1C in transfected cells. J Virol (1992) 1.44
Selective membrane permeabilization by the rotavirus VP5* protein is abrogated by mutations in an internal hydrophobic domain. J Virol (2000) 1.40
Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals. EMBO J (2003) 1.38
Binding of adenovirus and its external proteins to Triton X-114. Dependence on pH. J Biol Chem (1985) 1.38
Adenovirus-dependent increase in cell membrane permeability. J Biol Chem (1985) 1.34
Rotaviruses induce an early membrane permeabilization of MA104 cells and do not require a low intracellular Ca2+ concentration to initiate their replication cycle. J Virol (1997) 1.32
Genetic analysis of adenovirus type 2. I. Isolation and genetic characterization of temperature-sensitive mutants. J Virol (1975) 1.30
The proteinase polypeptide of adenovirus serotype 2 virions. Virology (1990) 1.28
Structural stability of adenovirus type 5. J Pharm Sci (2003) 1.17
The concentration of Ca2+ that solubilizes outer capsid proteins from rotavirus particles is dependent on the strain. J Virol (1996) 1.16
Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4. J Virol (1999) 1.14
Requirement for vacuolar H+ -ATPase activity and Ca2+ gradient during entry of rotavirus into MA104 cells. J Virol (2002) 1.14
Adenovirus-dependent release of choline from plasma membrane vesicles at an acidic pH is mediated by the penton base protein. J Virol (1994) 1.12
Thermodynamics of fusion peptide-membrane interactions. Biochemistry (2003) 1.10
Adenovirus protein-protein interactions: molecular parameters governing the binding of protein VI to hexon and the activation of the adenovirus 23K protease. J Gen Virol (1995) 1.06
Adenovirus protein-protein interactions: hexon and protein VI. J Gen Virol (1994) 1.05
Functionally distinct subpopulations of cord blood CD34+ cells are transduced by adenoviral vectors with serotype 5 or 35 tropism. Mol Ther (2004) 0.95
Cleavage of rotavirus VP4 in vivo. J Gen Virol (1996) 0.89
Ionic strength- and temperature-induced K(Ca) shifts in the uncoating reaction of rotavirus strains RF and SA11: correlation with membrane permeabilization. J Virol (2002) 0.85
Characterization of the poliovirus 147S particle: new insights into poliovirus uncoating. Virology (2003) 0.82
Nuclear membrane proteins with potential disease links found by subtractive proteomics. Science (2003) 3.64
Differential regulation of cell motility and invasion by FAK. J Cell Biol (2003) 3.15
A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med (2002) 2.55
Mechanism of adenovirus neutralization by Human alpha-defensins. Cell Host Microbe (2008) 2.26
Crystal structure of human adenovirus at 3.5 A resolution. Science (2010) 2.17
Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments. J Virol (2006) 1.96
Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol (2007) 1.91
Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice. Hum Gene Ther (2003) 1.85
Tpr is localized within the nuclear basket of the pore complex and has a role in nuclear protein export. J Cell Biol (2002) 1.79
Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. J Virol (2004) 1.77
Nucleocytoplasmic transport: navigating the channel. Traffic (2003) 1.66
Energy- and temperature-dependent transport of integral proteins to the inner nuclear membrane via the nuclear pore. J Cell Biol (2004) 1.58
The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol Ther (2005) 1.54
Flexibility of the adenovirus fiber is required for efficient receptor interaction. J Virol (2003) 1.49
Beta1 integrin mediates internalization of mammalian reovirus. J Virol (2006) 1.43
Importin beta contains a COOH-terminal nucleoporin binding region important for nuclear transport. J Cell Biol (2003) 1.43
Molecular basis for the recognition of a nonclassical nuclear localization signal by importin beta. Mol Cell (2002) 1.42
Switch from capsid protein import to adenovirus assembly by cleavage of nuclear transport signals. EMBO J (2003) 1.38
The cell adhesion molecule "CAR" and sialic acid on human erythrocytes influence adenovirus in vivo biodistribution. PLoS Pathog (2009) 1.37
CryoEM structure at 9A resolution of an adenovirus vector targeted to hematopoietic cells. J Mol Biol (2005) 1.35
Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog (2010) 1.34
Influence of cargo size on Ran and energy requirements for nuclear protein import. J Cell Biol (2002) 1.30
Functional genetic and biophysical analyses of membrane disruption by human adenovirus. J Virol (2011) 1.28
Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production. Mol Cell Proteomics (2011) 1.28
Adenovirus. Curr Top Microbiol Immunol (2010) 1.27
Cryo-electron microscopy structure of adenovirus type 2 temperature-sensitive mutant 1 reveals insight into the cell entry defect. J Virol (2009) 1.27
Preferential activation of Toll-like receptor nine by CD46-utilizing adenoviruses. J Virol (2006) 1.27
Nuclear envelope transmembrane proteins (NETs) that are up-regulated during myogenesis. BMC Cell Biol (2006) 1.26
The nuclear membrane proteome: extending the envelope. Trends Biochem Sci (2005) 1.25
Sumoylation regulates nuclear localization of lipin-1alpha in neuronal cells. PLoS One (2009) 1.20
Overlapping functions of nuclear envelope proteins NET25 (Lem2) and emerin in regulation of extracellular signal-regulated kinase signaling in myoblast differentiation. Mol Cell Biol (2009) 1.19
An N-terminal domain of adenovirus protein VI fragments membranes by inducing positive membrane curvature. Virology (2010) 1.17
Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy. J Virol (2007) 1.13
Direct evidence from single-cell analysis that human {alpha}-defensins block adenovirus uncoating to neutralize infection. J Virol (2010) 1.12
Protein structure and oligomerization are important for the formation of export-competent HIV-1 Rev-RRE complexes. Protein Sci (2008) 1.12
Regulation of myoblast differentiation by the nuclear envelope protein NET39. Mol Cell Biol (2009) 1.11
Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors. J Virol (2011) 1.09
Virus yoga: the role of flexibility in virus host cell recognition. Trends Microbiol (2004) 1.08
Cryo-electron microscopy structure of an adenovirus-integrin complex indicates conformational changes in both penton base and integrin. J Virol (2009) 1.08
Transcriptional activation of the adenoviral genome is mediated by capsid protein VI. PLoS Pathog (2012) 1.06
Integrin and defensin modulate the mechanical properties of adenovirus. J Virol (2012) 1.04
Neutralizing antibody blocks adenovirus infection by arresting microtubule-dependent cytoplasmic transport. J Virol (2008) 1.04
The stability of the nuclear lamina polymer changes with the composition of lamin subtypes according to their individual binding strengths. J Biol Chem (2004) 1.03
The size-wise nucleus: nuclear volume control in eukaryotes. J Cell Biol (2007) 1.02
Phospholipid scramblase 1 is imported into the nucleus by a receptor-mediated pathway and interacts with DNA. Biochemistry (2004) 1.02
Antiviral cyclic D,L-alpha-peptides: targeting a general biochemical pathway in virus infections. Bioorg Med Chem (2005) 1.02
Splicing of human immunodeficiency virus RNA is position-dependent suggesting sequential removal of introns from the 5' end. Nucleic Acids Res (2005) 1.02
Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways. J Virol (2006) 1.02
Reconstitution of nuclear import in permeabilized cells. Methods Mol Biol (2009) 1.01
Cross-talk between snurportin1 subdomains. Mol Biol Cell (2005) 1.00
Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic. J Biol Chem (2007) 0.99
Spatiotemporal dynamics of adenovirus membrane rupture and endosomal escape. J Virol (2012) 0.97
Vault nanoparticles containing an adenovirus-derived membrane lytic protein facilitate toxin and gene transfer. ACS Nano (2009) 0.95
Increased susceptibility to DNA virus infection in mice with a GCN2 mutation. J Virol (2011) 0.95
DDX1 is an RNA-dependent ATPase involved in HIV-1 Rev function and virus replication. J Mol Biol (2011) 0.95
Adenovirus composition, proteolysis, and disassembly studied by in-depth qualitative and quantitative proteomics. J Biol Chem (2014) 0.94
Virion factors that target Daxx to overcome intrinsic immunity. J Virol (2013) 0.93
Identification of a small molecule inhibitor of importin β mediated nuclear import by confocal on-bead screening of tagged one-bead one-compound libraries. ACS Chem Biol (2010) 0.93
Viral weapons of membrane destruction: variable modes of membrane penetration by non-enveloped viruses. Curr Opin Virol (2011) 0.93
Repression of classical nuclear export by S-nitrosylation of CRM1. J Cell Sci (2009) 0.93
In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity. Virology (2005) 0.92
Conservation of fiber structure and CD46 usage by subgroup B2 adenoviruses. Virology (2008) 0.92
NET37, a nuclear envelope transmembrane protein with glycosidase homology, is involved in myoblast differentiation. J Biol Chem (2009) 0.91
Small molecule peptidomimetic inhibitors of importin α/β mediated nuclear transport. Bioorg Med Chem (2010) 0.90
Structural variations in species B adenovirus fibers impact CD46 association. J Virol (2008) 0.90
Guiding plant virus particles to integrin-displaying cells. Nanoscale (2012) 0.90
Parvoviruses cause nuclear envelope breakdown by activating key enzymes of mitosis. PLoS Pathog (2013) 0.90
Targeted vault nanoparticles engineered with an endosomolytic peptide deliver biomolecules to the cytoplasm. ACS Nano (2011) 0.89
Synergy of silent and hot spot mutations in importin beta reveals a dynamic mechanism for recognition of a nuclear localization signal. J Biol Chem (2003) 0.89
Nuclear RNAs confined to a reticular compartment between chromosome territories. Exp Cell Res (2005) 0.89
Adenovirus infection: taking the back roads to viral entry. Curr Biol (2003) 0.87
An intrinsically disordered region of the adenovirus capsid is implicated in neutralization by human alpha defensin 5. PLoS One (2013) 0.87
CD46-utilizing adenoviruses inhibit C/EBPbeta-dependent expression of proinflammatory cytokines. J Virol (2005) 0.86
Karyopherin binding interactions and nuclear import mechanism of nuclear pore complex protein Tpr. BMC Cell Biol (2009) 0.86
Analysis of nuclear protein import and export in vitro using fluorescent cargoes. Methods Mol Biol (2002) 0.85
High temporal resolution imaging reveals endosomal membrane penetration and escape of adenoviruses in real time. Methods Mol Biol (2013) 0.84
Enhancement of gene transfer to human myeloid cells by adenovirus-fiber complexes. Mol Ther (2006) 0.84
Disulfide-bond formation by a single cysteine mutation in adenovirus protein VI impairs capsid release and membrane lysis. Virology (2012) 0.84
Immunotherapy with a posttranscriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma. Blood (2002) 0.83
Erlins restrict SREBP activation in the ER and regulate cellular cholesterol homeostasis. J Cell Biol (2013) 0.83
Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectors. Cancer Lett (2003) 0.83
Herpesvirus hijacks an integrin. Nat Cell Biol (2002) 0.83
A MAP6-related protein is present in protozoa and is involved in flagellum motility. PLoS One (2012) 0.82
Identification of novel integral membrane proteins of the nuclear envelope with potential disease links using subtractive proteomics. Novartis Found Symp (2005) 0.82
Multidrug resistance-1 (MDR-1): a new target for T cell-based immunotherapy. FASEB J (2004) 0.82
MudPIT: A powerful proteomics tool for discovery. Discov Med (2003) 0.82
Structural basis of nonenveloped virus cell entry. Adv Protein Chem (2003) 0.81
In vivo transduction of photoreceptors or ciliary body by intravitreal injection of pseudotyped adenoviral vectors. Mol Ther (2003) 0.81
The identification of an adenovirus receptor by using affinity capture and mass spectrometry. Chembiochem (2004) 0.80
The structure of the NXF2/NXT1 heterodimeric complex reveals the combined specificity and versatility of the NTF2-like fold. J Mol Biol (2011) 0.80
Fast generation of stable cell lines expressing fluorescent marker molecules to study pathogen induced processes. Methods Mol Biol (2013) 0.78
Organellar proteomics: the prizes and pitfalls of opening the nuclear envelope. Genome Biol (2002) 0.76
Reduction of a 4q35-encoded nuclear envelope protein in muscle differentiation. Biochem Biophys Res Commun (2009) 0.76
Coagulation factor defends adenovirus from immune attack. Nat Med (2013) 0.75